A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

Clinical trial NCT07121192 · COMPLETED

Trial details

NCT number: NCT07121192
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2025-08-25
Primary completion: 2026-05-11
Enrollment: 776

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.